You are here : Home > Services > Supply of Intermediates
Pharmaceutical Intermediates Supply

The CARBOGEN AMCIS Ltd. Manchester facility focuses on process optimization and the synthesis of nonGMP pharmaceutical intermediates.  The large-scale production capacities (up to 4’500 L, with a temperature range from -80°C to +250 °C) allow the efficient production of early-phase APIs and large-scale intermediates under nonGMP conditions that can be further processed at the CARBOGEN AMCIS Swiss’ facilities. The extensive distillation capabilities offer a significant expansion to the purification capabilities of CARBOGEN AMCIS AG.

News
16 February 2018
CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland

11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection


Events
DCAT week

World ADC Berlin